Which 5-HT3 receptor antagonist has the longest duration of action and is preferred for prophylaxis of postoperative nausea and vomiting?

Explanation

## 5-HT3 Receptor Antagonists: Duration and Efficacy **Key Point:** Palonosetron has the longest half-life and duration of action among 5-HT3 antagonists, providing superior prophylaxis for postoperative nausea and vomiting (PONV). ### Comparative Pharmacokinetics | Agent | Half-life | Duration of Action | Typical Dose | Clinical Use | |---|---|---|---|---| | Ondansetron | 3–4 hours | 4–6 hours | 4–8 mg IV | Standard prophylaxis | | Granisetron | 4–9 hours | 24 hours | 1–3 mg IV | Moderate duration | | Tropisetron | 7–9 hours | 24 hours | 2–5 mg IV | European use; moderate duration | | Palonosetron | 40 hours | 48–72 hours | 0.075 mg IV | **Longest duration; superior efficacy** | ### Why Palonosetron Is Superior **High-Yield:** Palonosetron advantages: 1. **Longest half-life (40 hours)** — sustained receptor occupancy 2. **Crosses blood–brain barrier more effectively** — better central action 3. **Higher receptor binding affinity** — stronger antagonism 4. **Covers delayed PONV** — effective for 48–72 hours post-op 5. **Lower dose requirement** — 0.075 mg vs. 4–8 mg for ondansetron **Mnemonic:** **PALO** = **P**otent, **A**ffinity, **L**ong-acting, **O**ptimal prophylaxis **Clinical Pearl:** Palonosetron is especially valuable in high-risk PONV patients (female, non-smoker, history of motion sickness, opioid use) and for procedures with high emetogenic potential. **Warning:** Ondansetron, despite being the most commonly used, has a shorter duration (4–6 hours) and is less effective for delayed PONV (>6 hours post-op). Do not confuse frequency of use with superiority. [cite:Miller's Anesthesia 8e Ch 35]